OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Novel cytokine–antibody fusion protein, N-820, to enhance the functions of ex vivo expanded natural killer cells against Burkitt lymphoma
Yaya Chu, Gaurav Nayyar, Nang Kham Su, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001238-e001238
Open Access | Times Cited: 13
Yaya Chu, Gaurav Nayyar, Nang Kham Su, et al.
Journal for ImmunoTherapy of Cancer (2020) Vol. 8, Iss. 2, pp. e001238-e001238
Open Access | Times Cited: 13
Showing 13 citing articles:
Immunocytokines with target cell–restricted IL-15 activity for treatment of B cell malignancies
Latifa Zekri, Ilona Hagelstein, Melanie Märklin, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 737
Open Access | Times Cited: 7
Latifa Zekri, Ilona Hagelstein, Melanie Märklin, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 737
Open Access | Times Cited: 7
Combined therapy of CAR-IL-15/IL-15Rα-T cells and GLIPR1 knockdown in cancer cells enhanced anti-tumor effect against gastric cancer
Jianbin Ye, Qiaoyuan Liu, Yunxuan He, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Jianbin Ye, Qiaoyuan Liu, Yunxuan He, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 6
Safety, Tolerability, and Long-Term Clinical Outcomes of an IL-15 analogue (N-803) Admixed with Bacillus Calmette-Guérin (BCG) for the Treatment of Bladder Cancer
Charles J. Rosser, Sergei Tikhonenkov, Jeffrey W. Nix, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 36
Charles J. Rosser, Sergei Tikhonenkov, Jeffrey W. Nix, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 36
Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy
Alexandra A. Wolfarth, Swati Dhar, Jack B. Goon, et al.
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Alexandra A. Wolfarth, Swati Dhar, Jack B. Goon, et al.
Immune Network (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 14
Efficiently targeting neuroblastoma with the combination of anti-ROR1 CAR NK cells and N-803 in vitro and in vivo in NB xenografts
Yaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200820-200820
Open Access | Times Cited: 2
Yaya Chu, Gaurav Nayyar, Meijuan Tian, et al.
Deleted Journal (2024) Vol. 32, Iss. 2, pp. 200820-200820
Open Access | Times Cited: 2
The Future of Natural Killer Cell Immunotherapy for B Cell Non-Hodgkin Lymphoma (B Cell NHL)
Yaya Chu, Margaret Lamb, Mitchell S. Cairo, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 3, pp. 381-403
Open Access | Times Cited: 9
Yaya Chu, Margaret Lamb, Mitchell S. Cairo, et al.
Current Treatment Options in Oncology (2022) Vol. 23, Iss. 3, pp. 381-403
Open Access | Times Cited: 9
Killer instincts: natural killer cells as multifactorial cancer immunotherapy
Sarah Nersesian, Emily B. Carter, Stacey N. Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Sarah Nersesian, Emily B. Carter, Stacey N. Lee, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 5
Immune Predictors of Response after Bacillus Calmette–Guérin Treatment in Non-Muscle-Invasive Bladder Cancer
Marta Rodríguez-Izquierdo, Carmen Gómez del Cañizo, Carolina Rubio, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5554-5554
Open Access | Times Cited: 4
Marta Rodríguez-Izquierdo, Carmen Gómez del Cañizo, Carolina Rubio, et al.
Cancers (2023) Vol. 15, Iss. 23, pp. 5554-5554
Open Access | Times Cited: 4
Cellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma
Yaya Chu, Aliza Gardenswartz, Caroline Diorio, et al.
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 1, pp. 101442-101442
Closed Access | Times Cited: 2
Yaya Chu, Aliza Gardenswartz, Caroline Diorio, et al.
Best Practice & Research Clinical Haematology (2023) Vol. 36, Iss. 1, pp. 101442-101442
Closed Access | Times Cited: 2
Advances in engineering and delivery strategies for cytokine immunotherapy
Margaret Bohmer, Yonger Xue, Katarina E. Jankovic, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 5, pp. 579-595
Open Access | Times Cited: 2
Margaret Bohmer, Yonger Xue, Katarina E. Jankovic, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 5, pp. 579-595
Open Access | Times Cited: 2
Impact of alemtuzumab-mediated lymphocyte depletion on SIV reservoir establishment and persistence
Benjamin Varco-Merth, Morgan Chaunzwa, Derick M. Duell, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012496-e1012496
Open Access
Benjamin Varco-Merth, Morgan Chaunzwa, Derick M. Duell, et al.
PLoS Pathogens (2024) Vol. 20, Iss. 8, pp. e1012496-e1012496
Open Access
Donor chimerism and immune reconstitution following haploidentical transplantation in sickle cell disease
Yaya Chu, Julie‐An Talano, Lee Ann Baxter‐Lowe, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1
Yaya Chu, Julie‐An Talano, Lee Ann Baxter‐Lowe, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 1
Fine-Tuning the Immune Response Against Cancer with Antibody-Cytokine Fusion Proteins
Sol Ferrero, Matías Gatto, Gustavo Helguera
Springer eBooks (2023), pp. 1-28
Closed Access
Sol Ferrero, Matías Gatto, Gustavo Helguera
Springer eBooks (2023), pp. 1-28
Closed Access
